StreetInsider.com News Articles

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—ACLX, DBRG, AVO, and CVGW

Mon, 09 Mar 2026 11:32:00 -0400

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --

Arcellx, Inc. (NASDAQ: ACLX) related to its sale to Gilead Sciences, Inc. Under the terms of the proposed transaction,

Form 10-K/A CALAVO GROWERS INC For: Oct 31

Mon, 02 Mar 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260302/26093814.html

Form 10-K/A CALAVO GROWERS INC For: Oct 31

Mon, 02 Mar 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260302/26093814.html

Form 8-K/A CALAVO GROWERS INC For: Jan 14

Mon, 02 Mar 2026 15:38:00 -0400

si-local-file:///var/storage/secattach/20260302/26091560.html

Form 8-K/A CALAVO GROWERS INC For: Jan 14

Mon, 02 Mar 2026 15:38:00 -0400

si-local-file:///var/storage/secattach/20260302/26091560.html

Form SCHEDULE 13G CALAVO GROWERS INC Filed by: Fourth Sail Capital LP

Tue, 24 Feb 2026 09:46:00 -0400

si-local-file:///var/storage/secattach/20260224/26048434.html